The long non-coding MALAT-1 RNA indicates a poor prognosis in NSCLC and induces migration and tumor growth
L. H. Schmidt, T. Spieker, S. Koschmieder, J. Humberg, A. Hascher, E. Bulk, A. Marr, L. Hilljean, W. Berdel, C. Müller-Tidow, R. Wiewrodt (Muemster, Ostercappeln, Germany)
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Session: Progress in pathology of lung cancer
Session type: Poster Discussion
Number: 1480
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. H. Schmidt, T. Spieker, S. Koschmieder, J. Humberg, A. Hascher, E. Bulk, A. Marr, L. Hilljean, W. Berdel, C. Müller-Tidow, R. Wiewrodt (Muemster, Ostercappeln, Germany). The long non-coding MALAT-1 RNA indicates a poor prognosis in NSCLC and induces migration and tumor growth. Eur Respir J 2011; 38: Suppl. 55, 1480
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The long non-coding MALAT-1 stimulates cellular growth, migration and proliferation Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
A low endothelial cell proliferation fraction, a measurement of ongoing angiogenesis, is associated with poor prognosis in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006
Overexpression of inhibitor of DNA-binding proteins and angiogenic markers have higher impact on survival of non small cell lung cancer patients Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012
MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2 Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Fascin-1 overexpression predicts a poor prognosis in non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
Decreased expression of FENDRR, a lung mesenchymal long non-coding RNA, regulates fibroblast phenotypes in IPF through NOX4. Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017
EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020
Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells Source: Eur Respir J 2006; 28: Suppl. 50, 325s Year: 2006
Overexpression of LincR-PICALM promotes lung cancer proliferation and metastasis by miR-199a-3p suppression and cis- regulation Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019
Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer Source: Eur Respir J 2013; 41: 1172-1178 Year: 2013
CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016
Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer Source: Eur Respir J 2004; 23: 14-19 Year: 2004
Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006
Comparing the prognostic impacts of angiogenesis, lymphangiogenesis and lymphatic invasion (LI) in small cell lung carcinomas (SCLC) Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
MDM-2 gene amplification is associated with poor prognosis in operable non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002
Is gender a prognostic factor in long term survival non-small cell lung cancer? Source: Eur Respir J 2002; 20: Suppl. 38, 185s Year: 2002
Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Quantification of telomerase activity is important in predicting prognosis of patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 482s Year: 2005
The effect of siRNA on invasion capability of small cell lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
The risk of distant metastases and prognosis prediction in early stage squamous cell lung cancer (SqCLC) by means of 3 microRNAs expression assessment Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011